Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Discover various wealth accumulation methods and strategies to enhance your financial growth. Start implementing them now.
28,655 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A small board-game importer plans to manufacture Monopoly in the United States after tariffs push production home, a ...
A California jury confronts a high-stakes question: can the way social apps are built cause harm to young users? The ...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
As the EU tightens its MiCA rules, BitGo CEO warns of a potential massive stablecoin crisis if USD-backed issuers fai...
Hidden costs are rewriting the cost of homeownership. Property taxes and insurance are rising faster than many buyers...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...
Supermicro, a key Nvidia partner, has not named a permanent CFO more than a year after an EY-led review urged leaders...
As layoffs linger in tech and startups recalibrate, candidates confront the toughest interview question: why were you...
As Stanford’s AI Index shows lagging adoption in the U.S., analysts say the real payoff comes from integration and tr...
Utilities are no longer safe havens in 2026 as higher yields and climate liabilities challenge traditional income arg...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...